Apr 06, 2020
Prime Therapeutics launches PreserveRx(SM) gene therapy financial protection
Apr 03, 2020
Gracell Announces China MNPA Acceptance of Investigational New Drug Application for GC007g Cell Therapy for CD19 Positive Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Apr 01, 2020
Locana Expands Leadership Team with Appointment of Micah Mackison, as Chief Business Officer
Mar 31, 2020
REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAV® Technology Platform for the Treatment of Rare Metabolic Disorder
Mar 25, 2020
Global Viral Vector and Plasmid DNA Manufacturing Market to Surpass US$ 2,205.6 Million by 2027 - CMI
Mar 24, 2020
Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies
Mar 12, 2020
Global CNS Drug Delivery Market Insights & Outlook, 2017-2028 - Cell & Gene Therapies Will Play an Important Role in the Treatment of Neurological Disorders in the Future
Mar 10, 2020
PhRMA Report Shows Nearly 400 Cell and Gene Therapies in Development to Target a Broad Range of Diseases
Mar 10, 2020
Advanced Therapy Medicinal Products Market Size Worth $9.6 Billion by 2026: Grand View Research, Inc.
Mar 09, 2020
GEMoaB Announces First Patient Apheresed in a Phase IA Study With Lead Product Candidate From Rapidly Switchable Universal CAR-T Platform (UniCAR) in CD123 Positive Relapsed/Refractory Acute Leukemias
Mar 03, 2020
BioIVT Now Provides Same-day Delivery of Fresh Leukopaks and Immune Cell Products in the UK and Overnight to EU Locations
Mar 03, 2020
Avectas and CCRM Announce Collaboration to Accelerate Development of Novel Technology for Cell Therapies
Feb 26, 2020
REGENXBIO Reports Fourth Quarter and Full-Year 2019 Financial Results and Operational Highlights
Feb 24, 2020
Study Advances Development of Gene Therapy for x-Linked Retinitis Pigmentosa
Feb 24, 2020
Vigene Biosciences Awarded Patent for improvements in the packaging efficiency of recombinantly-modified adeno-associated virus (AAV)
Feb 20, 2020
LumaCyte Expands into Europe Tackling Expansive Vaccine and Cell and Gene Therapy Markets
Feb 20, 2020
BioMarin's Biologics License Application for Valoctocogene Roxaparvovec Accepted for Priority Review by FDA with Review Action Date of August 21, 2020
Feb 11, 2020
Encoded Therapeutics Expands Gene Therapy Leadership with Key Appointment and Promotion
Feb 10, 2020
Inovio Receives Authorization from the U.S. FDA To Begin Phase 1/2 Clinical Trial for INO-3107, a DNA Medicine To Treat a Rare Disease -- Recurrent Respiratory Papillomatosis (RRP)
Feb 07, 2020
Global Gene Therapy Market Opportunity & Clinical Trials Insight 2026